Bedfont Scientific Ltd. launches their new and improved FeNO monitor exclusively at the world’s largest European Respiratory Society Congress with a competition to win one.
Bedfont Scientific Ltd. launches their new and improved FeNO monitor exclusively at the world’s largest European Respiratory Society Congress with a competition to win one.
Medical device manufacturer, Bedfont, who have specialised in breath analysis for over 40 years, have announced a new and improved 2nd generation NObreath®. The FeNO monitor will be launched exclusively at ERS, the world’s largest European Respiratory Society Congress, which takes place this year September 15-19thin Paris.
The 2ndgeneration FeNO monitor is launched after the recent publication of the NICE guidance on Asthma: diagnosis, monitoring and chronic asthma management, to improve asthma care, which included the NObreath® FeNO monitor from Bedfont as a recommended device1,2.
To celebrate the exclusive launch, the second-generation family business will also be holding a competition at their stand where delegates will have the chance to be entered into a prize draw to win a new NObreath®.
Jason Smith, Managing Director, comments, “As a breath analysis medical device manufacturer who exports globally, ERS is a key congress for us to reconnect with our customers from around the world.We are thrilled to be launching the 2nd generation NObreath® exclusively at ERS this year as we feel it would be quite symbolic;this launch will bring the product full circle, as the very first NObreath® was too launched at an ERS Congress 11 years ago. We’re excited to show our customers what’s in store for the advancement of respiratory care.”
-ends-
REFERENCES
- Asthma: diagnosis, monitoring and chronic asthma management | Guidance and guidelines | NICE [Internet]. Nice.org.uk. 2018 [cited 24 April 2018]. Available from: https://www.nice.org.uk/guidance/ng80
- Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath | Guidance and guidelines | NICE [Internet]. Nice.org.uk. 2014 [cited 24 April 2018]. Available from: https://www.nice.org.uk/guidance/dg12
About Bedfont
Established in 1976, Bedfont® Scientific Limited is a second generation family company that has specialised in the design and manufacture of exhaled breath and gas monitoring instruments for medical, scientific and industrial markets globally, for over 40 years. Bedfont® is revered as a pioneer in the breath analysis market with their products now available in over 76 countries across the world thanks to their unprecedented network of appointed distributors. Their aim is to continue innovating and improving health worldwide.
Managing director: Mr Jason Smith
Registered office: Station Yard, Station Road, Harrietsham, Maidstone, Kent, ME17 1JA
Company Registration No: 1289798 (England & Wales)
Website: www.bedfont.com
CONTACT DETAILS
For further information please contact:
Kristina Sedge, PR &communications coordinator
T: +44 (0) 1622 851122E: kristina@bedfont.com
